Department of Plastic, Aesthetic and Maxillofacial Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Acta Biochim Biophys Sin (Shanghai). 2021 Mar 26;53(4):501-510. doi: 10.1093/abbs/gmab018.
The rate of fat graft survival is a critical aspect of successful surgery and has been a matter of concern for over 20 years. Owing to their anti-inflammatory effects and regenerative property, adipose-derived mesenchymal stem cells (AD-MSCs) have been adapted for clinical application in fat grafting, although the mechanism underlying their action remains unclear. Recently, exosomes derived from MSCs were suggested as a better alternative, and these exosomes have also been applied in diverse clinical therapies. Accumulating evidence suggests that MSCs modulate macrophage differentiation via exosome secretion, and the connection between macrophage regulation and the rate of fat graft survival has been established. Here, we identified that let-7c, the key factor in the regulatory process, is shuttled by AD-MSC-derived exosomes to downregulate the transcription factor CCAAT/enhancer-binding protein (C/EBP)-δ. The downregulation of C/EBP-δ resulted in the attenuation of pro-inflammatory M1 macrophages and elevation of anti-inflammatory M2 macrophages. These results suggest that AD-MSC-derived exosomes promote the survival of fat grafts by regulating macrophage polarization via let-7c. This is the first study to elucidate the mechanism underlying the promotion of the fat graft survival rate by AD-MSCs and to evaluate the immunotherapeutic potential of AD-MSC-derived exosomes in fat grafting.
脂肪移植成活率是手术成功的关键因素,这一问题已经困扰了人们 20 多年。脂肪来源间充质干细胞(AD-MSCs)具有抗炎和再生特性,已被应用于脂肪移植的临床治疗,但目前其作用机制尚不清楚。最近,人们提出 MSC 来源的外泌体是更好的选择,这些外泌体也已应用于多种临床治疗。越来越多的证据表明,MSC 通过外泌体分泌来调节巨噬细胞分化,并且已经确定了巨噬细胞调节与脂肪移植成活率之间的联系。在这里,我们发现,调节过程中的关键因子 let-7c 被 AD-MSC 衍生的外泌体转运,从而下调转录因子 CCAAT/增强子结合蛋白(C/EBP)-δ。C/EBP-δ 的下调导致促炎 M1 巨噬细胞减少和抗炎 M2 巨噬细胞增加。这些结果表明,AD-MSC 衍生的外泌体通过 let-7c 调节巨噬细胞极化来促进脂肪移植物的存活。这是首次阐明 AD-MSCs 促进脂肪移植物成活率的机制,并评估 AD-MSC 衍生的外泌体在脂肪移植中的免疫治疗潜力的研究。